AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Expleo Solutions Limited

₹852 -$106.35 (-11.10%)
BSE · 16 Sep 2026 05:53 UTC
Previous Close
₹859.4
Day Range
₹843₹880.1
Year Range
₹644.1₹1179
Market Cap
13.22B
AVG Volume
9.29K
Trailing/Forward PE
10.04/9.02
PEG ratio
0.42
Dividend Yield
12.91%
Next Earnings Date
2026-11-14
Primary Exchange
Bombay Stock ExchangeIN
Revenue (INR)
01B2B3B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Revenue (INR) by quarter
PeriodRevenue (INR)
27 Q12.92B
26 Q42.86B
26 Q32.34B
26 Q22.83B
26 Q12.6B
25 Q42.56B
25 Q32.58B
25 Q22.59B
25 Q12.52B
24 Q42.55B
Net Income (INR)
0200M400M600M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Net Income (INR) by quarter
PeriodNet Income (INR)
27 Q1341.8M
26 Q4416.7M
26 Q3160.48M
26 Q2397.59M
26 Q1204.25M
25 Q4240.76M
25 Q3197.8M
25 Q2354.85M
25 Q1239.02M
24 Q4156.97M
Operating Income (INR)
0250M500M750M1B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Operating Income (INR) by quarter
PeriodOperating Income (INR)
27 Q1384.77M
26 Q4368.18M
26 Q3333.7M
26 Q2975.11M
26 Q1220.52M
25 Q4319.51M
25 Q3280.66M
25 Q2941.47M
25 Q1294.37M
24 Q4310M
EBITDA (INR)
0200M400M600M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO EBITDA (INR) by quarter
PeriodEBITDA (INR)
27 Q1423.48M
26 Q4573.73M
26 Q3315.28M
26 Q2594.15M
26 Q1366.69M
25 Q4445.16M
25 Q3413.97M
25 Q2549.6M
25 Q1409.96M
24 Q4360.34M
Cash Flows (INR)
00.250.50.75124 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Cash Flows (INR) by quarter
PeriodCash Flows (INR)
27 Q10
26 Q40
26 Q30
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
EPS (INR)
010203024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO EPS (INR) by quarter
PeriodEPS (INR)
27 Q122.02
26 Q426.85
26 Q310.34
26 Q225.62
26 Q113.16
25 Q415.51
25 Q312.75
25 Q222.86
25 Q115.4
24 Q410.12
Expenses (INR)
0200M400M600M800M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Expenses (INR) by quarter
PeriodExpenses (INR)
27 Q1625.51M
26 Q4555.24M
26 Q3447.55M
26 Q20
26 Q10
25 Q4531.98M
25 Q30
25 Q20
25 Q1747.77M
24 Q4581.36M
Cash & Debt (INR)
01B2B3B4BCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Cash & Debt (INR) by quarter
PeriodCash & Debt (INR)
27 Q10
26 Q43.76B
26 Q30
26 Q23.66B
26 Q10
25 Q42.95B
25 Q30
25 Q23.4B
25 Q11.99B
24 Q41.99B
Debt ratios
-2-1.5-1-0.5024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Debt ratios by quarter
PeriodDebt ratios
27 Q10
26 Q4-1.99
26 Q30
26 Q2-1.9
26 Q10
25 Q4-1.46
25 Q30
25 Q2-1.69
25 Q1-1.23
24 Q4-1.11
Margins
0%20%40%60%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Margins by quarter
PeriodMargins
27 Q134.65%
26 Q432.26%
26 Q333.39%
26 Q237.12%
26 Q135.93%
25 Q436.44%
25 Q342.07%
25 Q239.99%
25 Q141.33%
24 Q434.97%
Return on Capital
0%2%4%6%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Return on Capital by quarter
PeriodReturn on Capital
27 Q14.4%
26 Q45.37%
26 Q32.28%
26 Q25.65%
26 Q13.21%
25 Q43.79%
25 Q32.95%
25 Q25.29%
25 Q13.91%
24 Q42.57%
Shares Outstanding
05M10M15M20M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Shares Outstanding by quarter
PeriodShares Outstanding
27 Q115.52M
26 Q415.52M
26 Q315.52M
26 Q215.52M
26 Q115.52M
25 Q415.52M
25 Q315.51M
25 Q215.52M
25 Q115.52M
24 Q415.52M
Dividends (INR)
050100150Jul 15Nov 15Jul 16Nov 16Jul 17Nov 17Jul 18Jul 23Feb 25Jul 26
EXPLEOSOL.BO Dividends (INR) by quarter
PeriodDividends (INR)
Jul 26110
Feb 2550
Jul 235
Jul 1820
Nov 174
Jul 1720
Nov 164
Jul 1620
Nov 154
Jul 1520
Book Value Per Share (INR)
020040060024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Book Value Per Share (INR) by quarter
PeriodBook Value Per Share (INR)
27 Q1500.21
26 Q4500.2
26 Q3453.39
26 Q2453.42
26 Q1409.68
25 Q4409.67
25 Q3432.25
25 Q2432
25 Q1393.76
24 Q4393.79
Total Assets (INR)
02.5B5B7.5B10B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EXPLEOSOL.BO Total Assets (INR) by quarter
PeriodTotal Assets (INR)
27 Q10
26 Q49.29B
26 Q30
26 Q29.16B
26 Q10
25 Q48.31B
25 Q30
25 Q28.76B
25 Q10
24 Q47.65B
PE Ratio
10152025med 14.51Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EXPLEOSOL.BO PE Ratio by quarter
PeriodPE Ratio
Sep 2611.31
Sep 2611.73
Sep 2611.87
Aug 2611.51
Aug 2611.79
Aug 2610.67
Aug 2610.98
Jul 2610.56
Jul 2610.57
Jul 2610.51
Jul 2610.7
Jul 2610.83
Jun 2612.69
Jun 2612.53
Jun 2612.16
Jun 2613.3
May 2613.45
May 2613.99
May 2613.75
May 2613.06
Apr 2612.57
Apr 2612.39
Apr 2612.84
Apr 2611.76
Apr 2611.18
Mar 2610.18
Mar 2610.77
Mar 2610.9
Mar 2611.3
Feb 2611.19
Feb 2612.37
Feb 2612.73
Feb 2613.01
Feb 2613.35
Jan 2613.62
Jan 2614.2
Jan 2614.3
Jan 2614.49
Dec 2515.45
Dec 2516.02
Dec 2515.88
Dec 2516.29
Nov 2517.3
Nov 2516.77
Nov 2516.73
Nov 2515.25
Oct 2515.83
Oct 2515.84
Oct 2515.75
Oct 2515.51
Oct 2515.63
Sep 2514.55
Sep 2515.62
Sep 2514.91
Sep 2515.35
Aug 2515.59
Aug 2515.83
Aug 2516.71
Aug 2516.77
Aug 2517.56
Jul 2518.43
Jul 2518.23
Jul 2518.8
Jul 2519.68
Jun 2520.96
Jun 2520.29
Jun 2520.36
Jun 2516.8
May 2517.25
May 2516.68
May 2515.27
May 2513.52
May 2513.81
Apr 2514.2
Apr 2514.17
Apr 2513.35
Apr 2512.95
Mar 2511.33
Mar 2512.5
Mar 2512.05
Mar 2512.65
Feb 2512.76
Feb 2514.25
Feb 2514.52
Feb 2516.74
Feb 2517.07
Jan 2517.98
Jan 2518.56
Jan 2518.51
Jan 2520.05
Dec 2423.07
Dec 2423.95
Dec 2423.67
Dec 2422.91
Nov 2422
Nov 2422.45
Nov 2420.17
Nov 2420.11
Oct 2420.06
Oct 2419.17
Free Cash Flow Yield
0%1%2%3%4%med 0%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EXPLEOSOL.BO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 260%
Sep 260%
Sep 260%
Aug 260%
Aug 260%
Aug 260%
Aug 260%
Jul 260%
Jul 260%
Jul 260%
Jul 260%
Jul 260%
Jun 260%
Jun 260%
Jun 260%
Jun 260%
May 260%
May 260%
May 260%
May 260%
Apr 260%
Apr 260%
Apr 260%
Apr 260%
Apr 260%
Mar 260%
Mar 260%
Mar 260%
Mar 260%
Feb 260%
Feb 260%
Feb 260%
Feb 260%
Feb 260%
Jan 260%
Jan 260%
Jan 260%
Jan 260%
Dec 250%
Dec 250%
Dec 250%
Dec 250%
Nov 250%
Nov 250%
Nov 250%
Nov 250%
Oct 250%
Oct 250%
Oct 250%
Oct 250%
Oct 250%
Sep 250%
Sep 250%
Sep 250%
Sep 250%
Aug 250%
Aug 250%
Aug 250%
Aug 250%
Aug 250%
Jul 250%
Jul 250%
Jul 250%
Jul 250%
Jun 250%
Jun 250%
Jun 250%
Jun 250%
May 250%
May 250%
May 250%
May 250%
May 250%
Apr 250%
Apr 250%
Apr 250%
Apr 250%
Mar 252.75%
Mar 252.49%
Mar 252.59%
Mar 252.46%
Feb 252.44%
Feb 252.19%
Feb 252.15%
Feb 251.86%
Feb 251.83%
Jan 251.73%
Jan 251.68%
Jan 251.68%
Jan 251.56%
Dec 242.51%
Dec 242.42%
Dec 242.45%
Dec 242.53%
Nov 242.63%
Nov 242.58%
Nov 242.87%
Nov 242.88%
Oct 242.89%
Oct 243.02%
Price to Sales
11.522.5med 1.45Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EXPLEOSOL.BO Price to Sales by quarter
PeriodPrice to Sales
Sep 261.26
Sep 261.3
Sep 261.32
Aug 261.28
Aug 261.31
Aug 261.18
Aug 261.22
Jul 261.17
Jul 261.17
Jul 261.17
Jul 261.19
Jul 261.2
Jun 261.23
Jun 261.22
Jun 261.18
Jun 261.29
May 261.31
May 261.36
May 261.34
May 261.27
Apr 261.22
Apr 261.2
Apr 261.25
Apr 261.14
Apr 261.09
Mar 261
Mar 261.06
Mar 261.07
Mar 261.11
Feb 261.1
Feb 261.22
Feb 261.25
Feb 261.28
Feb 261.32
Jan 261.34
Jan 261.4
Jan 261.41
Jan 261.43
Dec 251.49
Dec 251.55
Dec 251.53
Dec 251.57
Nov 251.67
Nov 251.62
Nov 251.62
Nov 251.47
Oct 251.53
Oct 251.53
Oct 251.52
Oct 251.5
Oct 251.51
Sep 251.47
Sep 251.57
Sep 251.5
Sep 251.55
Aug 251.57
Aug 251.59
Aug 251.68
Aug 251.69
Aug 251.77
Jul 251.86
Jul 251.84
Jul 251.89
Jul 251.98
Jun 251.94
Jun 251.88
Jun 251.89
Jun 251.56
May 251.6
May 251.54
May 251.41
May 251.25
May 251.28
Apr 251.32
Apr 251.31
Apr 251.24
Apr 251.2
Mar 251.22
Mar 251.34
Mar 251.29
Mar 251.36
Feb 251.37
Feb 251.53
Feb 251.56
Feb 251.8
Feb 251.83
Jan 251.93
Jan 251.99
Jan 251.99
Jan 252.15
Dec 242.19
Dec 242.27
Dec 242.25
Dec 242.17
Nov 242.09
Nov 242.13
Nov 241.91
Nov 241.91
Oct 241.9
Oct 241.82
EV/EBITDA
2.557.51012.515med 7.58Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EXPLEOSOL.BO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 265.22
Sep 265.49
Sep 265.57
Aug 265.35
Aug 265.52
Aug 264.81
Aug 265.01
Jul 264.74
Jul 264.75
Jul 264.71
Jul 264.83
Jul 264.91
Jun 267.39
Jun 267.3
Jun 267.09
Jun 267.75
May 267.84
May 268.16
May 268.01
May 267.61
Apr 267.32
Apr 267.22
Apr 267.48
Apr 266.85
Apr 266.52
Mar 263.92
Mar 264.26
Mar 264.33
Mar 264.56
Feb 264.49
Feb 265.17
Feb 265.37
Feb 265.53
Feb 265.73
Jan 265.88
Jan 266.22
Jan 266.27
Jan 266.38
Dec 258.68
Dec 259
Dec 258.92
Dec 259.15
Nov 259.72
Nov 259.42
Nov 259.4
Nov 258.57
Oct 258.89
Oct 258.9
Oct 258.85
Oct 258.71
Oct 258.78
Sep 256.8
Sep 257.41
Sep 257.01
Sep 257.26
Aug 257.39
Aug 257.53
Aug 258.03
Aug 258.07
Aug 258.52
Jul 259
Jul 258.89
Jul 259.22
Jul 259.71
Jun 2511.47
Jun 2511.1
Jun 2511.14
Jun 259.19
May 259.44
May 259.13
May 258.36
May 257.4
May 257.56
Apr 257.77
Apr 257.75
Apr 257.3
Apr 257.09
Mar 255.12
Mar 255.82
Mar 255.55
Mar 255.91
Feb 255.97
Feb 256.87
Feb 257.03
Feb 258.36
Feb 258.56
Jan 259.11
Jan 259.46
Jan 259.43
Jan 2510.35
Dec 2412.15
Dec 2412.67
Dec 2412.5
Dec 2412.06
Nov 2411.53
Nov 2411.8
Nov 2410.47
Nov 2410.44
Oct 2410.41
Oct 249.89
Price/Operating Cashflow
020406080med 23.15Jul 23Oct 23Feb 24May 24Aug 24Dec 24Mar 25
EXPLEOSOL.BO Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 2536.33
Mar 2540.08
Mar 2538.63
Mar 2540.57
Feb 2540.9
Feb 2545.68
Feb 2546.55
Feb 2553.67
Feb 2554.71
Jan 2557.65
Jan 2559.52
Jan 2559.36
Jan 2564.3
Dec 2439.81
Dec 2441.34
Dec 2440.85
Dec 2439.54
Nov 2437.96
Nov 2438.75
Nov 2434.81
Nov 2434.71
Oct 2434.62
Oct 2433.09
Oct 2436.5
Oct 2437.09
Oct 2436.31
Sep 2427.04
Sep 2427.3
Sep 2428.05
Sep 2427.03
Aug 2428.77
Aug 2427.56
Aug 2426.4
Aug 2426.95
Aug 2427.82
Jul 2426.59
Jul 2426.03
Jul 2427.09
Jul 2426.63
Jun 2418.68
Jun 2419.02
Jun 2419.08
Jun 2418.43
May 2418
May 2418.55
May 2419.76
May 2419.56
May 2419.84
Apr 2419.45
Apr 2419.81
Apr 2419.38
Apr 2419.83
Mar 2419.07
Mar 2419.8
Mar 2420.16
Mar 2420.98
Mar 2421.63
Feb 2421.51
Feb 2422.12
Feb 2422.4
Feb 2422.04
Jan 2422.24
Jan 2421.74
Jan 2422.04
Jan 2421.93
Dec 2320.43
Dec 2321.13
Dec 2321.42
Dec 2320.4
Dec 2321.06
Nov 2321.3
Nov 2320.63
Nov 2320.77
Nov 2321.47
Oct 2321.77
Oct 2322.04
Oct 2321.86
Oct 2322.33
Sep 2322.53
Sep 2323.77
Sep 2323.94
Sep 2324.35
Sep 2322.7
Aug 2322.76
Aug 2323.6
Aug 2323.54
Aug 2328.66
Jul 2326.46
Jul 2326.64
Jul 2327.19
Jul 2325.94
Jun 2326.6
Jun 2319.36
Jun 2319.92
Jun 2320.52
Jun 2319.05
May 2317.86
May 2318.58
May 2317.73
May 2316.83
Price to Book
1234med 2.24Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EXPLEOSOL.BO Price to Book by quarter
PeriodPrice to Book
Sep 261.72
Sep 261.78
Sep 261.8
Aug 261.75
Aug 261.79
Aug 261.62
Aug 261.67
Jul 261.6
Jul 261.6
Jul 261.6
Jul 261.62
Jul 261.64
Jun 261.81
Jun 261.79
Jun 261.73
Jun 261.9
May 261.92
May 261.99
May 261.96
May 261.86
Apr 261.79
Apr 261.77
Apr 261.83
Apr 261.68
Apr 261.59
Mar 261.51
Mar 261.59
Mar 261.61
Mar 261.67
Feb 261.65
Feb 261.83
Feb 261.88
Feb 261.92
Feb 261.97
Jan 262.01
Jan 262.1
Jan 262.11
Jan 262.14
Dec 252.42
Dec 252.51
Dec 252.49
Dec 252.56
Nov 252.71
Nov 252.63
Nov 252.63
Nov 252.39
Oct 252.48
Oct 252.48
Oct 252.47
Oct 252.43
Oct 252.45
Sep 252.36
Sep 252.54
Sep 252.42
Sep 252.49
Aug 252.53
Aug 252.57
Aug 252.71
Aug 252.72
Aug 252.85
Jul 252.99
Jul 252.96
Jul 253.05
Jul 253.19
Jun 252.97
Jun 252.87
Jun 252.88
Jun 252.38
May 252.44
May 252.36
May 252.16
May 251.91
May 251.95
Apr 252.01
Apr 252
Apr 251.89
Apr 251.83
Mar 251.84
Mar 252.03
Mar 251.96
Mar 252.06
Feb 252.08
Feb 252.32
Feb 252.36
Feb 252.72
Feb 252.78
Jan 252.93
Jan 253.02
Jan 253.01
Jan 253.26
Dec 243.55
Dec 243.69
Dec 243.65
Dec 243.53
Nov 243.39
Nov 243.46
Nov 243.11
Nov 243.1
Oct 243.09
Oct 242.95
Expleo Solutions Limited
EXPLEOSOL.BO
Stockpicker

Video analysis: EXPLEOSOL.BO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.